Does the combination of intravenous lidocaine and dexamethasone reduce the incidence of postoperative sore throat? A randomized controlled trial

IF 0.7 Q3 ANESTHESIOLOGY
Mostafa Abdelkhalek, Esraa M. Elzeiny, Amgad A. Zaghlol, Emad El Hefnawy, Mohamed Y. Makharita
{"title":"Does the combination of intravenous lidocaine and dexamethasone reduce the incidence of postoperative sore throat? A randomized controlled trial","authors":"Mostafa Abdelkhalek,&nbsp;Esraa M. Elzeiny,&nbsp;Amgad A. Zaghlol,&nbsp;Emad El Hefnawy,&nbsp;Mohamed Y. Makharita","doi":"10.1016/j.tacc.2024.101503","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The incidence of postoperative sore throat, cough, and hoarseness of voice remains significant, but the best method to reduce these symptoms is not yet definitive. The use of intravenous lidocaine combined with dexamethasone is a novel strategy to address these issues. This double-blind randomized controlled trial evaluated the incidence and severity of postoperative sore throat (POST) at rest and swallowing, cough, and hoarseness of voice by comparing the effects of a combination of intravenous lidocaine and dexamethasone versus intravenous dexamethasone alone.</div></div><div><h3>Methods</h3><div>One hundred forty patients, classified as American Society of Anesthesiologists physical status I or II, aged 18–60 years and scheduled for elective laparotomy requiring general anesthesia with endotracheal intubation for more than 120 min, were randomly assigned to receive either intravenous 8 mg dexamethasone (D group) or the same dose of dexamethasone combined with 1.5 mg/kg lidocaine (DL group). The incidence and severity of sore throat, cough, and hoarseness of voice were evaluated up to 24 h after surgery. The primary outcome measured was the incidence of POST at rest and swallowing.</div></div><div><h3>Results</h3><div>Data from 140 patients (70 patients in each group) was analyzed. The occurrence of a sore throat at rest was 41.4 % in group D and 21.4 % in group DL (P = .011). The incidence of postoperative sore throat (POST) when swallowing was 47.1 % for group D and 27.1 % for group DL (P = .014). Using dexamethasone combined with lidocaine reduced the severity of POST at rest and during swallowing at 1–2, 3, and 6 h after surgery. Multivariate logistic regression showed a reduction in POST incidence in the DL group (odds ratio, 0.4; 95 % confidence interval, 0.19–0.99; P = .05). There were no significant differences between the groups' incidence and severity of coughing or hoarseness.</div></div><div><h3>Conclusions</h3><div>Intravenous dexamethasone, combined with lidocaine, reduces the incidence and severity of postoperative sore throat at rest and during swallowing in patients requiring endotracheal intubation for over 120 min.</div></div>","PeriodicalId":44534,"journal":{"name":"Trends in Anaesthesia and Critical Care","volume":"59 ","pages":"Article 101503"},"PeriodicalIF":0.7000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Anaesthesia and Critical Care","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2210844024001722","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The incidence of postoperative sore throat, cough, and hoarseness of voice remains significant, but the best method to reduce these symptoms is not yet definitive. The use of intravenous lidocaine combined with dexamethasone is a novel strategy to address these issues. This double-blind randomized controlled trial evaluated the incidence and severity of postoperative sore throat (POST) at rest and swallowing, cough, and hoarseness of voice by comparing the effects of a combination of intravenous lidocaine and dexamethasone versus intravenous dexamethasone alone.

Methods

One hundred forty patients, classified as American Society of Anesthesiologists physical status I or II, aged 18–60 years and scheduled for elective laparotomy requiring general anesthesia with endotracheal intubation for more than 120 min, were randomly assigned to receive either intravenous 8 mg dexamethasone (D group) or the same dose of dexamethasone combined with 1.5 mg/kg lidocaine (DL group). The incidence and severity of sore throat, cough, and hoarseness of voice were evaluated up to 24 h after surgery. The primary outcome measured was the incidence of POST at rest and swallowing.

Results

Data from 140 patients (70 patients in each group) was analyzed. The occurrence of a sore throat at rest was 41.4 % in group D and 21.4 % in group DL (P = .011). The incidence of postoperative sore throat (POST) when swallowing was 47.1 % for group D and 27.1 % for group DL (P = .014). Using dexamethasone combined with lidocaine reduced the severity of POST at rest and during swallowing at 1–2, 3, and 6 h after surgery. Multivariate logistic regression showed a reduction in POST incidence in the DL group (odds ratio, 0.4; 95 % confidence interval, 0.19–0.99; P = .05). There were no significant differences between the groups' incidence and severity of coughing or hoarseness.

Conclusions

Intravenous dexamethasone, combined with lidocaine, reduces the incidence and severity of postoperative sore throat at rest and during swallowing in patients requiring endotracheal intubation for over 120 min.
静脉联合利多卡因和地塞米松是否能减少术后喉咙痛的发生率?随机对照试验
背景术后喉咙痛、咳嗽和声音嘶哑的发生率仍然很高,但减少这些症状的最佳方法尚未确定。静脉注射利多卡因联合地塞米松是解决这些问题的一种新策略。这项双盲随机对照试验通过比较静脉注射利多卡因和地塞米松与单独静脉注射地塞米松的效果,评估术后休息和吞咽时喉咙痛(POST)、咳嗽和声音嘶哑的发生率和严重程度。方法将140例年龄在18 ~ 60岁、美国麻醉学会评定为I级或II级的择期剖腹手术患者随机分为静脉注射地塞米松8mg (D组)和等量地塞米松联合利多卡因1.5 mg/kg (DL组)两组。术后24小时评估喉咙痛、咳嗽和声音嘶哑的发生率和严重程度。测量的主要结局是休息和吞咽时POST的发生率。结果分析140例患者资料,每组70例。静息时喉咙痛的发生率D组为41.4%,DL组为21.4% (P = 0.011)。术后吞咽时咽痛发生率D组为47.1%,DL组为27.1% (P = 0.014)。地塞米松联合利多卡因可降低术后1-2、3和6小时静息和吞咽时POST的严重程度。多因素logistic回归显示DL组POST发病率降低(优势比0.4;95%置信区间为0.19-0.99;p = 0.05)。两组患者咳嗽或声音嘶哑的发生率和严重程度无显著差异。结论静脉注射地塞米松联合利多卡因可降低术后静息及吞咽时咽痛的发生率和严重程度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
13.30%
发文量
60
审稿时长
33 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信